Nocturnal angina pectoris: Difference between revisions
Hardik Patel (talk | contribs) No edit summary |
Hardik Patel (talk | contribs) |
||
| Line 23: | Line 23: | ||
==Treatment== | ==Treatment== | ||
[[Nocturnal angina pectoris medical therapy|Medical Therapy]] | [[Nocturnal angina pectoris primary prevention|Primary Prevention]] | [[Nocturnal angina pectoris secondary prevention|Secondary Prevention]] | [[Nocturnal angina pectoris cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Nocturnal angina pectoris future or investigational therapies|Future or Investigational Therapies]] | [[Nocturnal angina pectoris medical therapy|Medical Therapy]] | [[Nocturnal angina pectoris surgery|Surgery]] | [[Nocturnal angina pectoris primary prevention|Primary Prevention]] | [[Nocturnal angina pectoris secondary prevention|Secondary Prevention]] | [[Nocturnal angina pectoris cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Nocturnal angina pectoris future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
Latest revision as of 14:48, 5 March 2013
|
Nocturnal angina pectoris Microchapters |
|
Differentiating Nocturnal Angina Pectoris from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Nocturnal angina pectoris On the Web |
|
American Roentgen Ray Society Images of Nocturnal angina pectoris |
|
Risk calculators and risk factors for Nocturnal angina pectoris |
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Pathophysiology
Causes
Differentiating Nocturnal Angina Pectoris from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies